{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:13:27Z","timestamp":1791893607660,"version":"4.3.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2017,7]]},"abstract":"\n Background and objectives<\/jats:title>\n Persons receiving outpatient hemodialysis are at risk for bloodstream and vascular access infections. The Centers for Disease Control and Prevention conducts surveillance for these infections through the National Healthcare Safety Network. We summarize 2014 data submitted to National Healthcare Safety Network Dialysis Event Surveillance.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n \n Dialysis facilities report three types of dialysis events (bloodstream infections; intravenous antimicrobial starts; and pus, redness, or increased swelling at the hemodialysis vascular access site). Denominator data consist of the number of hemodialysis outpatients treated at the facility during the first 2 working days of each month. We calculated dialysis event rates stratified by vascular access type (\n e.g.<\/jats:italic>\n , arteriovenous fistula, arteriovenous graft, or central venous catheter) and standardized infection ratios (comparing individual facility observed with predicted numbers of infections) for bloodstream infections. We described pathogens identified among bloodstream infections.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 6005 outpatient hemodialysis facilities reported dialysis event data for 2014 to the National Healthcare Safety Network. These facilities reported 160,971 dialysis events, including 29,516 bloodstream infections, 149,722 intravenous antimicrobial starts, and 38,310 pus, redness, or increased swelling at the hemodialysis vascular access site events; 22,576 (76.5%) bloodstream infections were considered vascular access related. Most bloodstream infections (63.0%) and access-related bloodstream infections (69.8%) occurred in patients with a central venous catheter. The rate of bloodstream infections per 100 patient-months was 0.64 (0.26 for arteriovenous fistula, 0.39 for arteriovenous graft, and 2.16 for central venous catheter). Other dialysis event rates were also highest among patients with a central venous catheter. Facility bloodstream infection standardized infection ratio distribution was positively skewed with a median of 0.84.\n Staphylococcus aureus<\/jats:italic>\n was the most commonly isolated bloodstream infection pathogen (30.6%), and 39.5% of\n S. aureus<\/jats:italic>\n isolates tested were resistant to methicillin.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The 2014 National Healthcare Safety Network Dialysis Event data represent nearly all United States outpatient dialysis facilities. Rates of infection and other dialysis events were highest among patients with a central venous catheter compared with other vascular access types. Surveillance data can help define the epidemiology of important infections in this patient population.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.11411116","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T20:20:11Z","timestamp":1498767611000},"page":"1139-1146","source":"Crossref","is-referenced-by-count":162,"title":["National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014"],"prefix":"10.2215","volume":"12","author":[{"given":"Duc B.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Shugart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"Lines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"xlv","DOI":"10.1016\/S0272-6386(99)70294-5","article-title":"Neutrophil function and infections in uremia.","volume":"33","author":"H\u00f6rl","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1681\/ASN.V95869","article-title":"EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.","volume":"9","author":"Hoen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1523-1755.2005.00364.x","article-title":"Bacterial infections in hemodialysis patients: Pathogenesis and prevention.","volume":"67","author":"Jaber","year":"2005","journal-title":"Kidney Int"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/ajkd.2002.31405","article-title":"Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access.","volume":"39","author":"Stevenson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1525-139X.2007.00379.x","article-title":"Dialysis surveillance report: National Healthcare Safety Network (NHSN)-data summary for 2006.","volume":"21","author":"Klevens","year":"2008","journal-title":"Semin Dial"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1067\/mic.2002.120904","article-title":"New national surveillance system for hemodialysis-associated infections: Initial results.","volume":"30","author":"Tokars","year":"2002","journal-title":"Am J Infect Control"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2215\/CJN.03050315","article-title":"Risk factors for infection-related hospitalization in In-center hemodialysis.","volume":"10","author":"Dalrymple","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/sdi.12094","article-title":"Multidrug-resistant organisms in dialysis patients.","volume":"26","author":"Calfee","year":"2013","journal-title":"Semin Dial"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1017\/ice.2015.90","article-title":"Outbreak of clostridium difficile infections at an outpatient hemodialysis facility-Michigan, 2012-2013.","volume":"36","author":"See","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"RR-5","key":"B11-20230813","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients.","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections.","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.02.352","article-title":"Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients.","volume":"56","author":"Patel","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1525-139x.2000.00030.x","article-title":"Description of a new surveillance system for bloodstream and vascular access infections in outpatient hemodialysis centers.","volume":"13","author":"Tokars","year":"2000","journal-title":"Semin Dial"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ajic.2016.02.009","article-title":"Dialysis event surveillance report: National healthcare safety network data summary, January 2007 through April 2011.","volume":"44","author":"Patel","year":"2016","journal-title":"Am J Infect Control"},{"key":"B24-20230813","first-page":"243","article-title":"Vital signs: Central line-associated blood stream infections--United States, 2001, 2008, and 2009.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.ajkd.2013.03.011","article-title":"Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report.","volume":"62","author":"Patel","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/ice.2016.22","article-title":"Sustained infection reduction in outpatient hemodialysis centers participating in a collaborative bloodstream infection prevention effort.","volume":"37","author":"Yi","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/ice.2015.265","article-title":"Completeness of methicillin-resistant staphylococcus aureus bloodstream infection reporting from outpatient hemodialysis facilities to the National Healthcare Safety Network, 2013.","volume":"37","author":"Nguyen","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/cid\/cit546","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011.","volume":"57","author":"Nguyen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1525-139X.2003.03009.x","article-title":"Infection with antimicrobial-resistant microorganisms in dialysis patients.","volume":"16","author":"Berns","year":"2003","journal-title":"Semin Dial"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/669869","article-title":"Antimicrobial use in outpatient hemodialysis units.","volume":"34","author":"Snyder","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1681\/ASN.2012010050","article-title":"Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.","volume":"23","author":"Chan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/sdi.12090","article-title":"Antimicrobial use and stewardship programs among dialysis centers.","volume":"26","author":"D\u2019Agata","year":"2013","journal-title":"Semin Dial"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.332.7555.1435","article-title":"Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: Prospective study.","volume":"332","author":"George","year":"2006","journal-title":"BMJ"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-159-9-201311050-00011","article-title":"Public reporting of health care-associated surveillance data: Recommendations from the healthcare infection control practices advisory committee.","volume":"159","author":"Talbot","year":"2013","journal-title":"Ann Intern Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201707000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:57Z","timestamp":1786369017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201707000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11411116","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}